• Online Features  This Article  • Full text  • PDF  • CME Course for This Article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Quality of Care  • Quality of Care, Other  • Urinary Tract Disorders  • Less Is More  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Eugene Lin, MD; Yogesh Bhusal, MD; Deborah Horwitz, MS, PA-C; Samuel A. Shelburne III, MD, PhD; Barbara W. Trautner, MD, PhD

Arch Intern Med. 2012;172(1):33-38. doi:10.1001/archinternmed.2011.565

Background  The purposes of this study were to investigate the clinical outcomes of enterococcal bacteriuria and to determine whether current management is adherent to Infectious Diseases Society of America guidelines.

Methods  We conducted a retrospective medical record review of patients from 2 academic teaching hospitals for 3 months (September 1 through November 30, 2009). Patients were classified as having urinary tract infection (UTI) or asymptomatic bacteriuria (ABU) by applying the guidelines. Antibiotic use was deemed appropriate in patients with UTI and inappropriate in ABU. Medical records were reviewed for Enterococcus cultured from another sterile site within 30 days.

Results  A total of 375 urine cultures growing Enterococcus were reviewed, with 339 cultures meeting inclusion criteria. Of these 339 episodes, 183 (54.0%) were classified as ABU and 156 (46.0%) as UTI. In 289 episodes accompanied by urinalysis, pyuria was associated with UTI in 98 of 140 episodes (70.0%) compared with 63 of 149 episodes of ABU (42.3%) (odds ratio, 3.19; 95% CI, 1.96-5.18). Providers inappropriately treated 60 of 183 episodes of ABU (32.8%) with antibiotics. In multivariate analysis, only pyuria was associated with the inappropriate use of antibiotics (odds ratio, 3.27; 95% CI, 1.49-7.18). Only 7 subsequent infections with Enterococcus occurred in the 339 episodes of bacteriuria overall (2.1%), with 2 of the 183 cases of ABU (1.1%) having distant infection.

Conclusions  Providers often overtreat enterococcal ABU with antibiotics, particularly in patients with pyuria. Given the low incidence of infectious complications, efforts should be made to optimize the use of antibiotics in enterococcal bacteriuria.

Author Affiliations: Section of Infectious Diseases, Department of Medicine (Drs Lin, Bhusal and Trautner and Ms Horwitz), and Department of Molecular Virology and Microbiology (Dr Trautner), Baylor College of Medicine, Houston Veterans Affairs Health Services Research & Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center (Dr Trautner), and Department of Infectious Diseases, MD Anderson Cancer Center (Dr Shelburne), Houston, Texas. Dr Lin is now with the Department of Internal Medicine, University of Pennsylvania, Philadelphia.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Enhancing the Safety of Hospitalized Patients: Who Is Minding the Antimicrobials?: Comment on "Overtreatment of Enterococcal Bacteriuria"
Scott A. Flanders and Sanjay Saint
Arch Intern Med. 2012;172(1):38-40.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Enhancing the Safety of Hospitalized Patients: Who Is Minding the Antimicrobials?: Comment on "Overtreatment of Enterococcal Bacteriuria"
Flanders and Saint
Arch Intern Med 2012;172:38-40.
FULL TEXT